- Home
- APLT vs MRM Comparison
APLT vs MRM Comparison
Compare APLT & MRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | APLT | MRM |
|---|---|---|
| Founded | 2016 | 2000 |
| Country | United States | Japan |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.0M | 15.8M |
| IPO Year | 2019 | 2020 |
Fundamental Metrics
Financial Performance| Metric | APLT | MRM |
|---|---|---|
| Price | $0.10 | $1.73 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $1.25 | N/A |
| AVG Volume (30 Days) | ★ 11.6M | 97.3K |
| Earning Date | 11-13-2025 | 05-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.04 |
| Revenue | $1,000,000.00 | ★ $55,915,220.00 |
| Revenue This Year | $124.18 | N/A |
| Revenue Next Year | $25.00 | N/A |
| P/E Ratio | ★ N/A | $41.19 |
| Revenue Growth | N/A | ★ 12.79 |
| 52 Week Low | $0.09 | $0.34 |
| 52 Week High | $1.50 | $4.45 |
Technical Indicators
Market Signals| Indicator | APLT | MRM |
|---|---|---|
| Relative Strength Index (RSI) | 28.21 | 32.75 |
| Support Level | $0.09 | $1.77 |
| Resistance Level | $0.10 | $1.92 |
| Average True Range (ATR) | 0.01 | 0.12 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 34.74 | 9.80 |
Price Performance
Historical ComparisonAbout APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About MRM MEDIROM Healthcare Technologies Inc.
MEDIROM Healthcare Technologies Inc provides health services. The company is a franchiser and operator of healthcare salons and operates in segments namely Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty Segment. The company generates a majority of its revenue from the Relaxation Salon business segment. Geographically, the company generates a maximum share of its revenue from Japan.